Orapharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Improving Oral Health and Overall Health | OraPharma |
| Description | OraPharma is focused on improving patients' lives through the connection between oral health and overall health. |
| Keywords | orapharma, oral health and overall health |
Server Information
| WebSite | |
| Host IP | 45.60.82.248 |
| Location | United States |
Related Websites
| Site | Rank |
| arestinprofessional.com | #2,870,541 |
| hansamed.net | #5,837,464 |
| ossixusa.com | #4,480,347 |
| dentalambitions.com | #5,579,124 |
More to Explore
Orapharma.com Valuation
|
US$16,734
Last updated: Nov 21, 2020
Orapharma.com has global traffic rank of 2,037,787. Orapharma.com has an estimated worth of US$ 16,734, based on its estimated Ads revenue. Orapharma.com receives approximately 1,528 unique visitors each day. Its web server is located in United States, with IP address 45.60.82.248. According to SiteAdvisor, orapharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$16,734 |
| Daily Ads Revenue | US$9 |
| Monthly Ads Revenue | US$275 |
| Yearly Ads Revenue | US$3,346 |
| Daily Unique Visitors | 1,528 |
| Note: All traffic and earnings values are estimates. | |
Traffic Ranks
| Global Rank | 2,037,787 |
| Delta (90 Days) | 0 |
| Most Popular In Country | N/A |
| Country Rank | N/A |
DNS Records
| Host | Type | TTL | Data |
| orapharma.com | A | 3599 | IP: 45.60.82.248 |
| orapharma.com | A | 3599 | IP: 45.60.73.248 |
| orapharma.com | MX | 599 | Priority: 10 Target: orapharma-com.mail.protection.outlook.com. |
| orapharma.com | NS | 21599 | Target: ns2.markmonitor.com. |
| orapharma.com | NS | 21599 | Target: ns4.markmonitor.com. |
| orapharma.com | NS | 21599 | Target: ns1.markmonitor.com. |
| orapharma.com | NS | 21599 | Target: ns3.markmonitor.com. |
| orapharma.com | NS | 21599 | Target: ns6.markmonitor.com. |
| orapharma.com | NS | 21599 | Target: ns7.markmonitor.com. |
| orapharma.com | NS | 21599 | Target: ns5.markmonitor.com. |
| orapharma.com | TXT | 3599 | TXT: _globalsign-domain-verification=kQxeXON0egy4P9JMIYPsCCMHOiLxgagLNTuXToOchp |
| orapharma.com | TXT | 3599 | TXT: MS=ms87102745 |
| orapharma.com | TXT | 3599 | TXT: v=spf1 mx include:mktomail.com include:spf.protection.outlook.com ~all |
| orapharma.com | TXT | 3599 | TXT: _globalsign-domain-verification=ht0ZrZXsYUjtg1qvNLtTN2gtgGc_FFAPfNDZtPSw02 |
| orapharma.com | SOA | 21599 | MNAME: ns1.markmonitor.com. RNAME: hostmaster.markmonitor.com. Serial: 2020082501 Refresh: 86400 Retry: 3600 Expire: 2592000 Minimum TTL: 172800 |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Location: https://www.orapharma.com/
Content-Length: 0
Connection: close
HTTP/1.1 200 OK
Cache-Control: public, no-cache="Set-Cookie"
Content-Type: text/html; charset=utf-8
Set-Cookie: dnn_IsMobile=False; path=/; HttpOnly
Set-Cookie: language=en-US; path=/; HttpOnly
Set-Cookie: .ASPXANONYMOUS=IhQrJQTVBxludQ47PRC4QaFRaw2s3WbTyLjMPq0OqWGsY54QwPaJYqQamxwSjU-X5RHzJYjOZbVRta1HLztuWKButkP0LY35vtj1wjdIataSn0BY0; expires=Sat, 30-Jan-2021 05:34:50 GMT; path=/; HttpOnly
Set-Cookie: Analytics_VisitorId=48ac3454-ae19-475c-b9d4-a370d40384e7; expires=Mon, 21-Dec-2020 18:54:50 GMT; path=/; HttpOnly
Set-Cookie: Analytics=SessionId=6728ba33-f553-4778-8fe5-4a5bc0c41326&TabId=11983&ContentItemId=-1; expires=Sat, 21-Nov-2020 19:54:50 GMT; path=/; HttpOnly
X-UA-Compatible: IE=edge
Set-Cookie: dnn_IsMobile=False; path=/; HttpOnly
Set-Cookie: language=en-US; path=/; HttpOnly
Set-Cookie: .ASPXANONYMOUS=IhQrJQTVBxludQ47PRC4QaFRaw2s3WbTyLjMPq0OqWGsY54QwPaJYqQamxwSjU-X5RHzJYjOZbVRta1HLztuWKButkP0LY35vtj1wjdIataSn0BY0; expires=Sat, 30-Jan-2021 05:34:50 GMT; path=/; HttpOnly
Set-Cookie: Analytics_VisitorId=48ac3454-ae19-475c-b9d4-a370d40384e7; expires=Mon, 21-Dec-2020 18:54:50 GMT; path=/; HttpOnly
Set-Cookie: Analytics=SessionId=6728ba33-f553-4778-8fe5-4a5bc0c41326&TabId=11983&ContentItemId=-1; expires=Sat, 21-Nov-2020 19:54:50 GMT; path=/; HttpOnly
Set-Cookie: __RequestVerificationToken=ZBKesjfCJ99QBwq6GvwxhGGVH54dIry3sHXOEHH95nU45UVwRr9DXbMu_zHGmCVM3X3jbw2; path=/; HttpOnly
X-XSS-Protection: 1; mode=block
X-Frame-Options: SAMEORIGIN
Date: Sat, 21 Nov 2020 18:54:50 GMT
Set-Cookie: visid_incap_1843303=biAL1hw5RZ+Exr9yP7pojXpiuV8AAAAAQUIPAAAAAABPtDfMLlkYBbph2pCbaTXj; expires=Sun, 21 Nov 2021 08:04:42 GMT; HttpOnly; path=/; Domain=.orapharma.com
Set-Cookie: nlbi_1843303=jWuGEgEeXzDUkFOlIYWFKwAAAABFvkWy0QEBT4SP8/7LAl0n; path=/; Domain=.orapharma.com
Set-Cookie: incap_ses_1172_1843303=t5dOD5jnOkoh0Fxu9MdDEHpiuV8AAAAAa8+8LZ+LrQlmgnmrVPPqpA==; path=/; Domain=.orapharma.com
Set-Cookie: ___utmvmKFBuYcYzB=VhFqXqRulUV; path=/; Max-Age=900
Set-Cookie: ___utmvaKFBuYcYzB=uVgaiTL; path=/; Max-Age=900
Set-Cookie: ___utmvbKFBuYcYzB=XZQ
XHKOxalk: JtB; path=/; Max-Age=900
X-CDN: Incapsula
Transfer-Encoding: chunked
X-Iinfo: 9-152517004-152517007 NNNN CT(20 61 0) RT(1605984890236 13) q(0 0 1 0) r(1 1) U12
|
Orapharma.com Whois Information
Domain Name: ORAPHARMA.COM Registry Domain ID: 2319387_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2020-06-07T09:32:34Z Creation Date: 1997-07-10T04:00:00Z Registry Expiry Date: 2022-07-09T04:00:00Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.MARKMONITOR.COM Name Server: NS2.MARKMONITOR.COM Name Server: NS3.MARKMONITOR.COM Name Server: NS4.MARKMONITOR.COM Name Server: NS5.MARKMONITOR.COM Name Server: NS6.MARKMONITOR.COM Name Server: NS7.MARKMONITOR.COM DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/ Domain Name: orapharma.com Registry Domain ID: 2319387_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2020-06-07T02:32:34-0700 Creation Date: 1997-07-09T21:00:00-0700 Registrar Registration Expiration Date: 2022-07-08T00:00:00-0700 Registrar: MarkMonitor, Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895770 Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited) Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited) Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited) Registrant Organization: Valeant Pharmaceuticals North America LLC Registrant State/Province: NJ Registrant Country: US Registrant Email: Select Request Email Form at https://domains.markmonitor.com/whois/orapharma.com Admin Organization: Valeant Pharmaceuticals North America LLC Admin State/Province: NJ Admin Country: US Admin Email: Select Request Email Form at https://domains.markmonitor.com/whois/orapharma.com Tech Organization: Valeant Pharmaceuticals North America LLC Tech State/Province: NJ Tech Country: US Tech Email: Select Request Email Form at https://domains.markmonitor.com/whois/orapharma.com Name Server: ns4.markmonitor.com Name Server: ns3.markmonitor.com Name Server: ns7.markmonitor.com Name Server: ns6.markmonitor.com Name Server: ns1.markmonitor.com Name Server: ns5.markmonitor.com Name Server: ns2.markmonitor.com DNSSEC: unsigned URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/ MarkMonitor Domain Management(TM) Protecting companies and consumers in a digital world. Visit MarkMonitor at https://www.markmonitor.com Contact us at +1.8007459229 In Europe, at +44.02032062220 |